Data Science representatives from Eagle Genomics, Babylon Health, Touch Surgery, Myrecovery, Creation were interviewed by Cognition X.
All these companies use machine learning in different ways either to analyse the genome, diagnostic/surgical implications or helping patients directly.
All of the panel agree that AI is coming back after going through a ‘nuclear’ winter.
Eagle Genomics feel that by 2025 there will be over 250 million patients with their genomes sequenced. This constitutes several zetabytes of data. This cannot be analysed by humans but only machines. We have a burgeoning data management crisis that can be solved in no other way. We need to turn big data into actionable insights.
Babylon health say they want to make healthcare affordable to all – that is their vision. They believe in augmenting doctors and making them safer. Babylon feel the biggest need is in Africa. That is why they are working in Rwanda because the needs are so great.
They think that in the next 5 years there needs to be some sort of regulatory mechanism to govern the use of AI diagnostics. They want to improve the productivity of doctors not replace them.
Touch surgery feel that humans alone cannot deal with all the data alone. They feel that it is essential to use that data in order to learn how to make their product as good as they can. Currently they are trying to use machine learning to improve the user experience and training. They believe that the technology should also help the surgeon in the same way that power-assisted steering and GPS enhance the driving experience.
Myrecovery are analysing how their users are using the apps as well to try and predict their recovery. A lot of people complained about the US election predictions. Garbage in = garbage out. Longer term they see it as a core asset to the business. They feel that the present situation is unsustainable. We can’t compete with robots any more, we need to work with them in order to get the job done.
Creation feel that it will be essential in the future but at the present are focusing on building data sets and getting them verified by medical professionals. They talked about developing a system that could analyse a photo via a network – like instagram for medical diagnosis. They feel that doctors use social media quite a lot. Sometimes they have found doctors answering individual patients on social media. They feel the barriers are breaking down. They also sited the microbiome. He talked about machine sentiment analysis and how it is currently largely useless. Most ‘AI’ is still heavily dependant on human interaction to make it work but in the future this won’t be the case.
Then Charlie asked the panel what advice they would give to tech startups thinking about working in this field. Their advice was:
- Get good at selling yourself.
- You need to be in it for the long haul. (We are in the middle of a revolution).
- Be prepared to change your business model several times.
These are some of the new startups disrupting the health industry – possibly the largest industry on the planet.
The products I saw pitched were point of care cortisol testing and a novel method for delivering vaccines and preventing spoil. This is a fantastic initiative for new healthcare startups
Shafi Ahmed then introduced the topic of the ‘fourth’ industrial revolution.
The blurring of the lines between the physical and digital spheres.
It is about thinking differently in order to solve hard and complex problems. It will involve the interface of medicine, digital technology, societal changes, art and many other things.
It will involve:
Big Data / Informatics
Machine Learning / AI
This is just what we know the fourth revolution will involve. There are many other things as yet undiscovered which will be involved.
This beauty could revolutionise the admission of chest pain. It can more accurately diagnose ACS AND unstable angina in just 3 minutes in the ED. It’s currently going through studies to validate it but I can see it being very successful as it’s price point is only around £100k and it could save NHS trusts millions.
Creavomedtech only just formed. Based in Leeds with a strong support structure, good corporate backing and strong technical expertise linked to the university I think this is one to watch!
This platform by early sense could be useful for patients with dementia as a way to monitor them remotely. However, there are lots of cheaper bed alarms. At £3500 a bed I think this products USP is the monitoring rather than anything else.
This is not a new technology but it’s beginning to scale. Portable theatres and endoscopy units could help some hospitals who have capacity issues. This polentally also has a role in major incident management.
This is a context based health platform. More advanced than a normal EPR (electronic patient record) system. This uses AI to filter the data and produce a useful record. This tool is FANTASTIC, but they have not yet broken into the NHS because their marketing strategy is wrong. It took me ages to get what they are actually doing and I think thats why they are struggling here. THIS IS A PATIENT SAFETY TOOL NOT A ‘CONTEXTUALISATION’ ONE. If you read this then get in contact because I think I can help you.
There are many more innovative solutions here but these ones caught my eye. To see more visit the EXPO website.
How long will it be before these become mainstream reality?
From MAYO education
The main obstacle to mainstream adoption is currently cost. For instance if robotic porters were availabile this would massively streamline patient logistics in a hospital. However, at present they cost far more than human porters.
This is an example of a tele-opetated robotic system. What will come next will be semiautonomous robotic surgery and higher level task semiautomation but we are still some way off this and as Healthcare tends to lag behind other industries I suspect it will be ~2050 before we see significant progress in this area.
Either way the robots are coming. Are we ready?
Just saw a talk on Ustekinumab by Prof Ghosh. Looks like it might well be yet another weapon in the arsenal to treat treatment resistant Crohn’s.